title: Costs of illness and care in Parkinson's disease: an evaluation in six countries.
abstract: We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.
authors.affiliation: Department of Neurology, Philipps University Marburg, Rudolf-Bultmann-Strasse 8, Marburg, Germany.
authors.forename: Sonja
authors.initials: S
authors.lastname: von Campenhausen
authors.forename: Yaroslav
authors.initials: Y
authors.lastname: Winter
authors.forename: Antonio
authors.initials: A
authors.lastname: Rodrigues e Silva
authors.forename: Christina
authors.initials: C
authors.lastname: Sampaio
authors.forename: Evzen
authors.initials: E
authors.lastname: Ruzicka
authors.forename: Paolo
authors.initials: P
authors.lastname: Barone
authors.forename: Werner
authors.initials: W
authors.lastname: Poewe
authors.forename: Alla
authors.initials: A
authors.lastname: Guekht
authors.forename: Céu
authors.initials: C
authors.lastname: Mateus
authors.forename: Karl-P
authors.initials: KP
authors.lastname: Pfeiffer
authors.forename: Karin
authors.initials: K
authors.lastname: Berger
authors.forename: Jana
authors.initials: J
authors.lastname: Skoupa
authors.forename: Kai
authors.initials: K
authors.lastname: Bötzel
authors.forename: Sabine
authors.initials: S
authors.lastname: Geiger-Gritsch
authors.forename: Uwe
authors.initials: U
authors.lastname: Siebert
authors.forename: Monika
authors.initials: M
authors.lastname: Balzer-Geldsetzer
authors.forename: Wolfgang H
authors.initials: WH
authors.lastname: Oertel
authors.forename: Richard
authors.initials: R
authors.lastname: Dodel
authors.forename: Jens P
authors.initials: JP
authors.lastname: Reese
mesh_terms: D000553:Ambulatory Care / Q000191:economics*; D000978:Antiparkinson Agents / Q000191:economics* / Q000627:therapeutic use; D017281:Cost of Illness; D005060:Europe; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D008134:Long-Term Care / Q000191:economics*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy* / Q000191:economics*; D011795:Surveys and Questionnaires
chemical_list: D000978:Antiparkinson Agents